参考文献/References:
[1] COLLINS F S,VARMUS H.A new initiative on precision medicine[J].N Engl J Med,2015,372(9):793-795.
[2] REARDON S.Precision-medicine plan raises hopes[J].Nature,2015,517(7536):540.
[3] 贺林.新医学是解决人类健康问题的真正钥匙:需“精准”理解奥巴马的“精准医学计划”[J].遗传,2015,37(6):613-614.
[4] 郭晓强,黄卫人,蔡志明.癌症精准医学[J].科学,2015,67(5):28-31.
[5] 张如奎,徐增辉.浅论基因检测对肿瘤精准医疗的意义[J].中国医药生物技术,2016,11(2):103-109.
[6] 吴家睿.精确医学的主要特征[J].医学与哲学,2016,37(8A):1-18.
[7] 何明燕,夏景林,王向东.精准医学研究进展[J].世界临床药物,2015,36(6):418-422.
[8] 程旭东,蒋丽萍,毛凯晟.癌症的精准医疗[J].科技导报,2016,34(20):51-55.
[9] TOPOL E J.Individualized medicine from prewomb to tomb[J].Cell,2014,157(1):241-253.
[10] SANDLER A,GRAY R,PERRY M C,et al.Paclitaxel-carboplatin alone or with bevacizumab for non-small cell lung cancer[J].N Engl J Med,2006,355(24):2542-2550.
[11] TOPALIAN S L,HODI F S,BRAHMER J R,et al.Safety,activity,and immune correlates of anti-PD-1 antibody in cancer[J].N Engl J Med,2012,366(26):2443-2454.
[12] KANDA S,GOTO K,SHIRAISHI H,et al.Safety and efficacy of nivolumab and standard chemotherapy drug combination in patients with advanced non-small-cell lung cancer:a four arms phase Ib study[J].Ann Oncol,2016,pii:mdw416.
[13] YARDEN Y.The EGFR family and its ligands in human cancer:signaling mechanisms and therapeutic opportunities[J].Eur J Cancer,2001,37(4):S3-S8.
[14] COLLISSON E A,CAMPBELL J D,BROOKS A N,et al.Cancer Genome Altas Research Network.Comprehensive molecular profiling of lung adenocarcinoma[J].Nature,2014,511(7511):543-550.
[15] MITSUDOMI T,MORITA S,YATABE Y,et al.Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405):an open label,randomised phase 3 trial[J].Lancet Oncol,2010,11(2):121-128.
[16] ROSELL R,CARCERENY E,GERVAIS R,et al.Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC):a multicentre,open-label,randomised phase 3 trial[J].Lancet Oncol,2012,13(3):239-246.
[17] OTT P A,HODI F S,ROBERT C.CTLA-4 and PD-1/PD-L1 blockade:new immuno-therapeutic modalities with durable clinical benefit in melanoma patients[J].Clin Cancer Res,2013,19(19):5300-5309.
[28] LEDFORD H.End of cancer-genome project prompts rethink[J].Nature,2015,517 (7533):128-129.
相似文献/References:
[1]陈建丽,胡新荣.p16在肿瘤中的表达与人乳头瘤病毒感染的关系[J].新乡医学院学报,,():000.
[2]张明彩 贾红霞 赵卫星 秦志强 付佶.乳腺浸润性导管癌冰冻与石蜡切片细胞核的形态计量对比研究[J].新乡医学院学报,1999,16(02):110.
[3]周文科 综述 张新中 审校.岩斜区侧方手术入路的研究进展[J].新乡医学院学报,2000,17(06):470.
[4]于维霞,王玉红 郭悦鹏,杜荣,等.T细胞亚群测定鉴别结核性与癌性胸腔积液[J].新乡医学院学报,2000,17(01):032.
[5]刘 薇.妇科肿瘤25例动脉插管化疗的观察与护理[J].新乡医学院学报,2003,20(03):003.
[6]刘薇.妇科肿瘤25例动脉插管化疗的观察与护理[J].新乡医学院学报,2003,20(03):001.
[7]王磊,乔庆东,王光军,等.微创腔镜技术治疗输尿管梗阻72 例[J].新乡医学院学报,2010,27(06):610.
[8]郭康,李文才.运动相关蛋白1/CD9在肿瘤中的表达研究进展[J].新乡医学院学报,2010,27(04):419.
[9]张莉莉,黄青松.肿瘤干细胞的起源、分离及鉴定研究进展[J].新乡医学院学报,2012,29(01):000.
[10]职晓松,黄筱奕,訾晓渊,等.长链非编码RNA PVT1在肿瘤中的作用研究进展[J].新乡医学院学报,2016,33(3):243.[doi:10.7683/xxyxyxb.2016.03.022]
ZHI Xiaosong,HUANG Xiaoyi,ZI Xiaoyuan,et al.Research progress on the role of long-chain noncoding RNAPVT1 in tumors[J].Journal of Xinxiang Medical University,2016,33(10):243.[doi:10.7683/xxyxyxb.2016.03.022]